The present invention relates to a treatment system for percutaneous coronary angioplasty or peripheral angioplasty in which a dilation catheter is used to cross a lesion in order to dilate the lesion and restore normal blood flow in the artery. It is particularly useful when the lesion is a calcified lesion in the wall of the artery. Calcified lesions require high pressures (sometimes as high as 10-15 or even 30 atmospheres) to break the calcified plaque and push it back into the vessel wall. With such pressures comes trauma to the vessel wall which can contribute to vessel rebound, dissection, thrombus formation, and a high level of restenosis. Non-concentric calcified lesions can result in undue stress to the free wall of the vessel when exposed to high pressures. An angioplasty balloon when inflated to high pressures can have a specific maximum diameter to which it will expand but the opening in the vessel under a concentric lesion will typically be much smaller. As the pressure is increased to open the passage way for blood the balloon will be confined to the size of the opening in the calcified lesion (before it is broken open). As the pressure builds a tremendous amount of energy is stored in the balloon until the calcified lesion breaks or cracks. That energy is then released and results in the rapid expansion of the balloon to its maximum dimension and may stress and injure the vessel walls.
Recently, a new system and method has been contemplated for breaking up calcium deposits in, for example, arteries and veins. Such a system is described, for example in U.S. Patent Publication No. 2009/0312768, Published Dec. 17, 2009. Embodiments described therein include a catheter having balloon, such as an angioplasty balloon, at the distal end thereof arranged to be inflated with a fluid. Disposed within the balloon is a shock wave generator that may take the form of, for example, a pair of electrodes, which are coupled to a high voltage source at the proximal end of the catheter through a connector. When the balloon is placed adjacent a calcified region of a vein or artery and a high voltage pulse is applied across the electrodes, a shock wave is formed that propagates through the fluid and impinges upon the wall of the balloon and the calcified region. Repeated pulses break up the calcium without damaging surrounding soft tissue.
Each high voltage pulse causes an arc to form across the electrodes. The arc in turn causes a steam bubble to form. Each steam bubble has the potential of producing two shock waves, a leading edge shock wave as a result of bubble expansion and a trailing edge shock wave as a result of bubble collapse. The trailing edge shock waves exhibit highly variable energy levels and generally, much greater energy levels than the leading edge shock waves. The energy levels of the trailing edge shock waves are substantially dependent on the uniformity of the bubble collapse. The uniform collapse of spherical bubbles to a point appears to create the highest shock wave energies. Unfortunately, spherical bubble configuration requires a substantially larger space than is available in a balloon that must fit into a calcified vein or artery or even a ureter. In fact, the trailing edge shock wave can be substantially eliminated by confining the bubble to an irregular shape. As a result, for angioplasty or other cardiac and non-cardiac applications of shock waves, the trailing edge shock wave cannot be reliably relied upon to produce consistent results.
However, the leading edge shock waves formed by bubble expansion are a different matter. While exhibiting generally lower energies, they are more consistent in energy level. As a result, leading edge shock waves are good candidates for use in medical procedures such, for example, angioplasty or valvuloplasty.
Another consideration is the amount of energy represented by the high voltage applied to the electrodes. Each high voltage pulse removes a portion of the electrode material. Since the size of the electrodes must be small in order to fit into the calcified vein or artery, they are only capable of sustaining a limited numbers of high voltage pulses sufficient to form the shock wave resulting electrical arc.
Also, it has been learned that to sustain a leading edge shock wave, it is not necessary to sustain the high voltage throughout the shock wave. Sustaining the high voltage beyond some point after the initial arc does not lead to shock waves of any greater intensity. Further, since the bubbles are formed of steam, the steam produces heat which can increase the temperature of adjacent soft tissue. Just a two degree Celsius elevation in temperature above body temperature can result in tissue damage.
A still further important aspect of prior art attempts to use shock waves from electrical arcs for therapeutic purposes is that from the time the high voltage is first applied to the electrodes to the time in which the arc occurs there is a dwell time (Td) that is highly variable from one high voltage application to the next. To account for the dwell times that are long, prior art strategies have relied upon high voltage applications where all high voltage pulse durations or pulse widths are of the same length and of a length sufficient to extend through the longest of the anticipated dwell times plus the associated arc and steam bubble. As a result, when the dwell times are shorter than the maximum, the high voltage application durations are longer than necessary and can unnecessarily extend the arc and the steam bubble well beyond a time required to produce a shock wave of maximum intensity. The result is wasted energy, extended electrode erosion, and unnecessary heating of the adjoining tissue.
Hence, there is a need in the art to be able to control the energy applied to the electrodes of an electrical arc shock wave generator. More particularly, there is a need to control the applied energy to assure appropriate bubble and shock wave formation while at the same time conserving electrode material and assuring tissue safety. The present invention addresses these and other issues.
In one embodiment, a system includes a catheter including an elongated carrier, a balloon about the carrier in sealed relation thereto, the balloon being arranged to receive a fluid therein that inflates the balloon, and first and second electrodes within the balloon arranged to carry a voltage there-across including an initial high electrical voltage at an initial low current. The initial high electrical voltage causes an electrical arc to form across the first and second electrodes within the balloon. The electrical arc causes a gas bubble within the liquid, a high current to flow through the first and second electrodes, a decrease in the initial high electrical voltage, and a mechanical shock wave within the balloon. The system further includes a power source that provides the first and second electrodes with a drive voltage that creates the initial high electrical voltage at the initial current and that terminates the drive voltage in response to the decrease in the initial high electrical voltage.
The power source may include a voltage sensor that senses the voltage across the first and second electrodes. The voltage sensor is arranged to cause the power source to terminate the drive voltage when the voltage across the first and second electrodes decreases by more than a predetermined amount of voltage within less than a predetermined amount of time.
The predetermined amount of voltage may be on the order of one-hundred volts and the predetermined time may be on the order of about 0.1 microseconds. Alternatively, the predetermined amount of voltage may be on the order of five-hundred volts and the predetermined time may be on the order of about 0.5 microseconds.
The system may further include a temperature sensor within the balloon that senses temperature of the fluid within the balloon, and the power source may be further responsive to the temperature sensor. The temperature sensor may cause the power source to decrease energy applied to the first and second electrodes responsive to the temperature of the fluid within the balloon increasing to control the temperature of the fluid.
The temperature sensor may be arranged to cause the power source to decrease energy applied to the first and second electrodes responsive to the temperature of the fluid within the balloon increasing to above two degrees Celsius above ambient temperature.
The balloon may be a dilation balloon. The dilation balloon is preferably an angioplasty balloon.
The system may further include a timer that times a delay time in response to the decrease in the initial high electrical voltage and the power source may be arranged to terminate the drive voltage after the delay time is timed.
The power source may include a voltage sensor that senses voltage across the first and second electrodes and the voltage sensor may be arranged to cause the timer to time the delay time when the voltage across the first and second electrodes decreases by more than a predetermined amount of voltage within less than a predetermined amount of time. The predetermined amount of voltage may be on the order of one-hundred volts and the predetermined time is on the order of about 0.1 microseconds. Alternatively, the predetermined amount of voltage may be on the order of five-hundred volts and the predetermined time is on the order of about 0.5 microseconds.
In another embodiment, a system includes a catheter including an elongated carrier, the carrier having a guide wire lumen, a balloon having an inner surface about the carrier in sealed relation thereto, the balloon forming with the carrier, a channel arranged to receive a fluid that inflates the balloon, and first and second electrodes within the balloon between the carrier and the inner surface of the balloon. The first and second electrodes within the balloon are arranged to carry a voltage there-across including an initial high electrical voltage at an initial low current. The initial high electrical voltage causes an electrical arc to form across the first and second electrodes within the balloon. The electrical arc causes a gas bubble within the liquid, a high current to flow through the first and second electrodes, a decrease in the initial high electrical voltage, and a mechanical shock wave within the balloon. The system further includes a power source that provides the first and second electrodes with a drive voltage that creates the initial high electrical voltage at the initial current and that terminates the drive voltage in response to the decrease in the initial high electrical voltage.
In a further embodiment, a method includes the steps of:
providing a catheter including an elongated carrier, a balloon about the carrier in sealed relation thereto, the balloon being arranged to receive a fluid therein that inflates the balloon, and first and second electrodes within the balloon and introducing the fluid into the balloon to inflate the balloon. The method further includes the steps of applying a drive voltage across the first and second electrodes to form an electrical arc across the first and second electrodes, sensing voltage across the first and second electrodes and varying the application of the drive voltage across the first and second electrodes in response to sensed voltage across the first and second electrodes after the electrical arc is formed across the first and second electrodes.
The varying step may include terminating the application of the drive voltage across the first and second electrodes.
The application of the drive voltage may be terminated when the voltage across the first and second electrodes decreases by more than a predetermined amount of voltage within less than a predetermined amount of time. The predetermined amount of voltage may be on the order of one-hundred volts and the predetermined time is on the order of 0.1 microseconds. Alternatively, the predetermined amount of voltage may be on the order of five-hundred volts and the predetermined time is on the order of about 0.5 microseconds.
The method may further include the step of sensing temperature of the fluid within the balloon, and the varying step may include varying the drive voltage across the first and second electrodes in response to sensed temperature of the fluid. The varying step may include decreasing energy applied to the first and second electrodes responsive to the temperature of the fluid within the balloon increasing to control the temperature of the fluid. The energy applied to the first and second electrodes may be decreased responsive to the temperature of the fluid within the balloon increasing to above two degrees Celsius above ambient temperature.
The method may further include the step of timing a delay time when the voltage across the first and second electrodes decreases by more than a predetermined amount of voltage within less than a predetermined amount of time.
The predetermined amount of voltage may be on the order of one-hundred volts and the predetermined time is on the order of about 0.1 microseconds. The predetermined amount of voltage may alternatively be on the order of five-hundred volts and the predetermined time is on the order of about 0.5 microseconds.
The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further features and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like reference numerals identify identical elements, and wherein:
The sheath 21 forms with the guide wire member 28 a channel 27 through which fluid, such as saline, may be admitted into the balloon to inflate the balloon. The channel 27 further permits the balloon 26 to be provided with an electrode pair 25 including electrodes 22 and 24 within the fluid filled balloon 26.
As may be seen in
The electrical arcs between electrodes 22 and 24 in the fluid are used to generate shock waves in the fluid. Each pulse of high voltage applied to the electrodes 22 and 24 forms an arc across the electrodes. The voltage pulses may have amplitudes as low as 500 volts, but preferably, the voltage amplitudes are in the range of 1000 volts to 10,000 volts The balloon 26 may be filled with water or saline in order to gently fix the balloon in the walls of the artery or vein, for example, in direct proximity with the calcified lesion. The fluid may also contain an x-ray contrast to permit fluoroscopic viewing of the catheter during use. Once the catheter 20 is positioned with the guide wire (not shown), the physician or operator can start applying the high voltage pulses to the electrodes to form the shock waves that crack the calcified plaque. Such shockwaves will be conducted through the fluid, through the balloon, through the blood and vessel wall to the calcified lesion where the energy will break the hardened plaque without the application of excessive pressure by the balloon on the walls of the artery.
It has been found that effective shock wave intensity may be accomplished without holding the high voltage pulses on during the entire extent of their corresponding steam bubbles. Moreover, terminating the application of the high voltage before steam bubble collapse can serve to preserve electrode material, permitting a pair of electrodes to last for an increased number of applied high voltage pulses. Still further, as will be seen subsequently, early termination of the high voltage can also be used to advantage in controlling the temperature within the balloon fluid.
In operation, the microprocessor 90 through the optical driver 92, causes the switch 86 to apply the high voltage to the electrodes 22 and 24. The current sensed through resister 96 is monitored by the microprocessor 90 through the optical isolator 98. When the current flowing through the electrodes reaches a predetermined limit, as for example 50 amperes, the microprocessor 90 causes the application of the high voltage to be terminated. The forgoing occurs for each high voltage pulse applied to the electrodes 22 and 24. Each pulse creates a shock wave of consistent and useful intensity. Further, because the application of the high voltage is terminated early, the electrode material is preserved to lengthen the useful life of the electrodes.
The catheter 133 of system 134 is shown in a ureter 130. The ureter has a kidney stone 131 requiring treatment. According to this embodiment, voltage pulses are applied to the electrode pair 132 to produce leading edge shock waves as previously described. The shock waves propagate through the fluid within the ureter and impinge directly on the kidney stone 131. In a manner as previously described, the power source may be operated to maintain the energy applied to the electrode pair within limits to assure that the steam bubbles produced by the generated arcs do not harm the ureter. To that end, the amplitude or pulse rate of the applied voltages may be controlled. Hence, by controlling the energy of the current during the produced arc, such as by controlling the on time of the current, barotrauma to the ureter may be minimized even though a balloon is not employed as in previous embodiments. Of course, the system of
Referring now to the flow diagram 200 of
As a result of the foregoing, a maximum intensity shock wave is formed without wasting energy, without unduly eroding the electrodes, and without generating unnecessary heat. As may be appreciated, the delay timing may be employed to advantage in each of the embodiments disclosed herein including the embodiment of
The power source 280 has an output terminal 282 that may be coupled to electrode 22 of
In operation, the microprocessor 290 through the optical driver 292, causes the switch 286 to apply the high drive voltage (e.g., from about 1,500 V to about 4,000 V; about 3,000 V) to the electrodes 22 and 24. The output voltage sensed by the voltage sensing resistive divider 296 is monitored by the microprocessor 290 through the optical isolator 298. When the output voltage across the electrodes decreases by a predetermined amount within a predetermined amount of time as for example, by about 100 volts within about 0.1 microseconds or by about 500 volts within about 0.5 microseconds, the microprocessor 290 causes the application of the high voltage to be terminated. The forgoing occurs for each high voltage pulse applied to the electrodes 22 and 24. Each pulse creates a shock wave of consistent and useful intensity (i.e., such that the shock wave intensity is sufficient to crack a calcified lesion). Further, because the application of the high voltage is terminated early, the electrode material is preserved to lengthen the useful life of the electrodes.
Referring now to the flow diagram 400 of
While particular embodiments of the present invention have been shown and described, modifications may be made. It is therefore intended in the appended claims to cover all such changes and modifications which fall within the true spirit and scope of the invention as defined by those claims.
This application is a continuation of U.S. application Ser. No. 15/347,486, filed Nov. 9, 2016, which in turn was a divisional of U.S. application Ser. No. 14/218,858, filed Mar. 18, 2014, issued as U.S. Pat. No. 9,522,012 on Dec. 20, 2016, which was in turn, a continuation-in-part of U.S. application Ser. No. 13/615,107 filed on Sep. 13, 2012, issued as U.S. Pat. No. 9,333,000 on May 10, 2016, all of which are incorporated herein by reference in their entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3412288 | Ostrander | Nov 1968 | A |
3413976 | Roze | Dec 1968 | A |
3785382 | Schmidt-Kloiber et al. | Jan 1974 | A |
3902499 | Shene | Sep 1975 | A |
4027674 | Tessier et al. | Jun 1977 | A |
4662126 | Malcolm | May 1987 | A |
4671254 | Fair | Jun 1987 | A |
4685458 | Leckrone | Aug 1987 | A |
4809682 | Forssmann et al. | Mar 1989 | A |
4890603 | Filler | Jan 1990 | A |
4900303 | Lemelson | Feb 1990 | A |
5009232 | Hassler et al. | Apr 1991 | A |
5057103 | Davis | Oct 1991 | A |
5057106 | Kasevich et al. | Oct 1991 | A |
5078717 | Parins et al. | Jan 1992 | A |
5102402 | Dror et al. | Apr 1992 | A |
5103804 | Abele et al. | Apr 1992 | A |
5116227 | Levy | May 1992 | A |
5152767 | Sypal et al. | Oct 1992 | A |
5152768 | Bhatta | Oct 1992 | A |
5176675 | Watson et al. | Jan 1993 | A |
5245988 | Einars et al. | Sep 1993 | A |
5246447 | Rosen et al. | Sep 1993 | A |
5281231 | Rosen et al. | Jan 1994 | A |
5321715 | Trost | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5336234 | Vigil et al. | Aug 1994 | A |
5362309 | Carter | Nov 1994 | A |
5368591 | Lennox et al. | Nov 1994 | A |
5395335 | Jang | Mar 1995 | A |
5417208 | Winkler | May 1995 | A |
5425735 | Rosen et al. | Jun 1995 | A |
5472406 | de la Torre et al. | Dec 1995 | A |
5582578 | Zhong et al. | Dec 1996 | A |
5603731 | Whitney | Feb 1997 | A |
5609606 | O'Boyle | Mar 1997 | A |
5662590 | de la Torre et al. | Sep 1997 | A |
5893840 | Hull et al. | Apr 1999 | A |
5931805 | Brisken | Aug 1999 | A |
6007530 | Dornhofer et al. | Dec 1999 | A |
6033371 | Torre et al. | Mar 2000 | A |
6083232 | Cox | Jul 2000 | A |
6146358 | Rowe | Nov 2000 | A |
6186963 | Schwarze et al. | Feb 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6217531 | Reitmajer | Apr 2001 | B1 |
6277138 | Levinson et al. | Aug 2001 | B1 |
6287272 | Brisken et al. | Sep 2001 | B1 |
6352535 | Lewis et al. | Mar 2002 | B1 |
6367203 | Graham et al. | Apr 2002 | B1 |
6371971 | Tsugita et al. | Apr 2002 | B1 |
6398792 | O'Connor | Jun 2002 | B1 |
6406486 | De La Torre et al. | Jun 2002 | B1 |
6514203 | Bukshpan | Feb 2003 | B2 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6589253 | Cornish et al. | Jul 2003 | B1 |
6607003 | Wilson | Aug 2003 | B1 |
6638246 | Naimark et al. | Oct 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6736784 | Menne et al. | May 2004 | B1 |
6740081 | Hilal | May 2004 | B2 |
6755821 | Fry | Jun 2004 | B1 |
6939320 | Lennox | Sep 2005 | B2 |
6989009 | Lafontaine | Jan 2006 | B2 |
7066904 | Rosenthal et al. | Jun 2006 | B2 |
7241295 | Maguire | Jul 2007 | B2 |
7505812 | Eggers et al. | Mar 2009 | B1 |
7569032 | Naimark et al. | Aug 2009 | B2 |
8556813 | Cioanta et al. | Oct 2013 | B2 |
8728091 | Hakala et al. | May 2014 | B2 |
8747416 | Hakala et al. | Jun 2014 | B2 |
8888788 | Hakala et al. | Nov 2014 | B2 |
8956371 | Hawkins | Feb 2015 | B2 |
9005216 | Hakala et al. | Apr 2015 | B2 |
9011463 | Adams et al. | Apr 2015 | B2 |
9333000 | Hakala et al. | May 2016 | B2 |
9522012 | Adams | Dec 2016 | B2 |
9642673 | Adams et al. | May 2017 | B2 |
9993292 | Adams et al. | Jun 2018 | B2 |
10154799 | Van Der Weide et al. | Dec 2018 | B2 |
10159505 | Hakala et al. | Dec 2018 | B2 |
10517620 | Adams | Dec 2019 | B2 |
10517621 | Adams | Dec 2019 | B1 |
20010044596 | Jaafar | Nov 2001 | A1 |
20020045890 | Celliers et al. | Apr 2002 | A1 |
20020177889 | Brisken et al. | Nov 2002 | A1 |
20030004434 | Greco et al. | Jan 2003 | A1 |
20030176873 | Chernenko | Sep 2003 | A1 |
20030229370 | Miller | Dec 2003 | A1 |
20040044308 | Naimark et al. | Mar 2004 | A1 |
20040097963 | Seddon | May 2004 | A1 |
20040097996 | Rabiner et al. | May 2004 | A1 |
20040162508 | Uebelacker | Aug 2004 | A1 |
20040249401 | Rabiner et al. | Dec 2004 | A1 |
20040254570 | Hadjicostis et al. | Dec 2004 | A1 |
20050015953 | Keidar | Jan 2005 | A1 |
20050021013 | Visuri et al. | Jan 2005 | A1 |
20050113722 | Schultheiss | May 2005 | A1 |
20050113822 | Fuimaono et al. | May 2005 | A1 |
20050228372 | Truckai et al. | Oct 2005 | A1 |
20050251131 | Lesh | Nov 2005 | A1 |
20060004286 | Chang et al. | Jan 2006 | A1 |
20060184076 | Gill et al. | Aug 2006 | A1 |
20060190022 | Beyar et al. | Aug 2006 | A1 |
20060221528 | Li | Oct 2006 | A1 |
20070016112 | Schultheiss et al. | Jan 2007 | A1 |
20070088380 | Hirszowicz et al. | Apr 2007 | A1 |
20070156129 | Kovalcheck | Jul 2007 | A1 |
20070239082 | Schultheiss et al. | Oct 2007 | A1 |
20070239253 | Jagger et al. | Oct 2007 | A1 |
20070244423 | Zumeris et al. | Oct 2007 | A1 |
20070250052 | Wham | Oct 2007 | A1 |
20070282301 | Segalescu et al. | Dec 2007 | A1 |
20080097251 | Babaev | Apr 2008 | A1 |
20080188913 | Stone et al. | Aug 2008 | A1 |
20090041833 | Bettinger et al. | Feb 2009 | A1 |
20090247945 | Levit et al. | Oct 2009 | A1 |
20090254114 | Hirszowicz et al. | Oct 2009 | A1 |
20090312768 | Hawkins | Dec 2009 | A1 |
20100016862 | Hawkins et al. | Jan 2010 | A1 |
20100036294 | Mantell | Feb 2010 | A1 |
20100114020 | Hawkins et al. | May 2010 | A1 |
20100114065 | Hawkins | May 2010 | A1 |
20100121322 | Swanson | May 2010 | A1 |
20100305565 | Truckai et al. | Dec 2010 | A1 |
20110034832 | Cioanta et al. | Feb 2011 | A1 |
20110118634 | Golan | May 2011 | A1 |
20110166570 | Hawkins et al. | Jul 2011 | A1 |
20110257523 | Hastings et al. | Oct 2011 | A1 |
20110295227 | Hawkins et al. | Dec 2011 | A1 |
20120071889 | Mantell et al. | Mar 2012 | A1 |
20120095461 | Herscher et al. | Apr 2012 | A1 |
20120203255 | Hawkins et al. | Aug 2012 | A1 |
20120221013 | Hawkins et al. | Aug 2012 | A1 |
20130030431 | Adams | Jan 2013 | A1 |
20130030447 | Adams | Jan 2013 | A1 |
20130041355 | Heeren | Feb 2013 | A1 |
20130150874 | Kassab | Jun 2013 | A1 |
20140005576 | Adams et al. | Jan 2014 | A1 |
20140039513 | Hakala et al. | Feb 2014 | A1 |
20140046229 | Hawkins et al. | Feb 2014 | A1 |
20140052145 | Adams et al. | Feb 2014 | A1 |
20140052147 | Hakala et al. | Feb 2014 | A1 |
20140074111 | Hakala et al. | Mar 2014 | A1 |
20140074113 | Hakala et al. | Mar 2014 | A1 |
20140243820 | Adams et al. | Aug 2014 | A1 |
20140243847 | Hakala et al. | Aug 2014 | A1 |
20140288570 | Adams | Sep 2014 | A1 |
20150073430 | Hakala et al. | Mar 2015 | A1 |
20150238208 | Adams et al. | Aug 2015 | A1 |
20160183957 | Hakala et al. | Jun 2016 | A1 |
20170056035 | Adams | Mar 2017 | A1 |
20190254692 | Hakala et al. | Aug 2019 | A1 |
Number | Date | Country |
---|---|---|
1204242 | Jan 1999 | CN |
1269708 | Oct 2000 | CN |
1942145 | Apr 2007 | CN |
102057422 | May 2011 | CN |
102271748 | Dec 2011 | CN |
102765785 | Nov 2012 | CN |
3038445 | May 1982 | DE |
3038445 | Jun 1990 | DE |
0442199 | Aug 1991 | EP |
0571306 | Nov 1993 | EP |
0571306 | Nov 1993 | EP |
S62-275446 | Nov 1987 | JP |
S62-275446 | Nov 1987 | JP |
6-125915 | May 1994 | JP |
7-047135 | Feb 1995 | JP |
10-99444 | Apr 1998 | JP |
10-513379 | Dec 1998 | JP |
2002538932 | Nov 2002 | JP |
2004081374 | Mar 2004 | JP |
2005095410 | Apr 2005 | JP |
2005515825 | Jun 2005 | JP |
2006516465 | Jul 2006 | JP |
2007289707 | Nov 2007 | JP |
2007532182 | Nov 2007 | JP |
2008506447 | Mar 2008 | JP |
2011524203 | Sep 2011 | JP |
2012-508042 | Apr 2012 | JP |
WO-1996024297 | Aug 1996 | WO |
WO-199902096 | Jan 1999 | WO |
WO-2004069072 | Aug 2004 | WO |
WO-2005099594 | Oct 2005 | WO |
WO-2005102199 | Nov 2005 | WO |
WO-2006127158 | Nov 2006 | WO |
WO-2007149905 | Dec 2007 | WO |
WO-2009121017 | Oct 2009 | WO |
WO-2009152352 | Dec 2009 | WO |
WO-2010014515 | Feb 2010 | WO |
WO-2011143468 | Nov 2011 | WO |
WO-2013059735 | Apr 2013 | WO |
Entry |
---|
“FDA Clears Lithoplasty Balloon That Shatters Calcified Lesions With Ultrasound”, Diagnostic and Interventional Cardiology, Available Online at <https://www.dicardiology.com/product/fda-clearslithoplasty-balloon-shatters-calcified-lesions-ultrasound>, Sep. 16, 2016, pp. 1-5. |
“Top Cardiovascular Innovation Award”, Cardiovascular Research Technologies (CRT), 2015, p. 1. |
Advisory Action received for U.S. Appl. No. 12/482,995, dated Jun. 2, 2014, 3 pages. |
Advisory Action received for U.S. Appl. No. 12/482,995, dated Sep. 29, 2011, 2 pages. |
Advisory Action received for U.S. Appl. No. 12/581,295, dated Jul. 3, 2014, 3 pages. |
Advisory Action received for U.S. Appl. No. 13/049,199, dated Jun. 7, 2012, 3 pages. |
Advisory Action received for U.S. Appl. No. 13/267,383, dated Jan. 6, 2014, 4 pages. |
Advisory Action received for U.S. Appl. No. 13/615,107, dated Nov. 6, 2015, 3 pages. |
Ardley, T., (2008). “First Principles of a Gas Discharge Tube (GOT) Primary Protector”, Bourns, Rev. 2, Available Online at <https://www.mouser.com/pdfdocs/bourns_gdt_white_paper.pdf>, pp. 1-34. |
Bank of America Merrill Lynch, (2019). “A Simple Solution to a Difficult (and Large) Problem—Initiating Coverage of SWAY”, Shockwave Medical Inc., pp. 1-22. |
Bittl et al., (1993). “Coronary Artery Perforation during Excimer Laser Coronary Angioplasty”, Journal of the American College of Cardiology, 21(5):1158-1165. |
Bittl et al., (1993). “Publication Information—Coronary Artery Perforation during Excimer Laser Coronary Angioplasty”, Journal of the American College of Cardiology, 21(5):1158-1165, 6 pages. |
Brinton et al., (2016). “Publication Information—TCT-777 Safety and Performance of the Shockwave Medical Lithoplasty® System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase Disrupt Pad Study”, Journal of the American College of Cardiology, 68(18): Supplement, 5 pages. |
Brinton et al., (2016). “TCT-777 Safety and Performance of the Shockwave Medical Lithoplasty® System in Treating Calcified Peripheral Vascular Lesions: 6-Month Results from the Two-Phase Disrupt Pad Study”, Journal of the American College of Cardiology, vol. 68, No. 18, Supplement B, p. B314. |
Broyer et al., (1996). “High-Efficiency Shock-Wave Generator for Extracorporeal Lithotripsy”, Medical and Biological Engineering and Computing, 34:321-328. |
Cardiology Today's Intervention, (2019). “Shockwave Attracts Additional Investment from Abiomed, has IPO”, Available Online at <https://www.healio.com/cardiac-vascular-intervention/peripheral/news/online/%7Bf96c1e20-b4a9-4167-bdb8-254e86a8182a%7D/shockwave-attracts-additional-investm ent-from-abiomed-has-ipo>, pp. 1-2. |
Citel Inc., “Gas Discharge Overview”, Available Online at <http://www.citel.us/gas_discharge_tubes_overview.html>, pp. 1-2. |
Cleveland et al., (2000). “Design and Characterization of a Research Electrohydraulic Lithotripter Patterned after the Dornier HM3”, Review of Scientific Instruments, 71(6):2514-2525. |
Cleveland et al., (2012). “The Physics of ShockWave Lithotripsy”, Extracorporeal Shock Wave Lithotripsy Part IV, Chapter 38, pp. 317-332. |
Concise Description of Relevance Accompanying Third Party Preissuance Submission Under 37 CFR 1.290 for U.S. Appl. No. 16/694,712, filed Apr. 10, 2020, 27 pages. |
Connors et al., (2003). “Renal Nerves Mediate Changes in Contralateral Renal Blood Flow after Extracorporeal Shockwave Lithotripsy”, Nephron Physiol., 95:67-75. |
Deagon, Brian Technology—Shockwave Medical IPO Soars on First Day of Trading Investor's Business Daily, Available Online at <https://www.investors.com/news/technology/shockwave-medical-ipo-soars-trading/> Mar. 7, 2019, pp. 1-15. |
Decision of Inter Partes Review for U.S. Pat. No. 8,728,091, by the Patent Trial and Appeal Board dated Jul. 11, 2019, pp. 1-32. |
Decision to Grant received for European Patent Application No. 13756766.5, dated May 27, 2016, 2 pages. |
Decision to Grant received for Japanese Patent Application No. 2011-513694, dated Oct. 7, 2014, 3 pages. |
Declaration of Dr. Morten Olgaard Jensen, Dec. 6, 2018, 138 pages. |
Declaration of Natalie J. Grace on Apr. 14, 2019, pp. 1-5. |
Declaration of William Patrick Stephens on Apr. 14, 2019, pp. 1-6. |
Dodd, A. T. S., (1842). “Two Cases of Calculus in the Bladder, in which Lithotripsy was Performed”, Provincial Medical & Surgical Journal, 3(71):368-370. |
Elmansy et al., (2016). “Publication Information—Recent Advances in Lithotripsy Technology and Treatment Strategies: A Systematic Review Update”, International Journal of Surgery, vol. 36, Part D, pp. 1-6. |
Elmansy et al., (2016). “Recent Advances in Lithotripsy Technology and Treatment Strategies: A Systematic Review Update”, International Journal of Surgery, 36:676-680. |
Extended European Search Report (includes Supplementary European Search Report and Search Opinion) received for European Patent Application No. 09763640.1, dated Oct. 10, 2013, 5 pages. |
Extended European Search Report received for European Patent Application No. 13827971.6, dated Apr. 12, 2016, 8 pages. |
Final Office Action received for U.S. Appl. No. 12/482,995, dated Feb. 20, 2014, 11 pages. |
Final Office Action received for U.S. Appl. No. 12/482,995, dated Jul. 22, 2011, 14 pages. |
Final Office Action received for U.S. Appl. No. 12/501,619, dated Feb. 21, 2012, 12 pages. |
Final Office Action received for U.S. Appl. No. 12/581,295, dated Jun. 5, 2014, 14 pages. |
Final Office Action received for U.S. Appl. No. 12/581,295, dated Mar. 28, 2013, 8 pages. |
Final Office Action received for U.S. Appl. No. 13/049,199, dated Apr. 4, 2012, 10 pages. |
Final Office Action received for U.S. Appl. No. 13/049,199, dated Aug. 11, 2014, 8 pages. |
Final Office Action received for U.S. Appl. No. 13/267,383, dated May 28, 2015, 12 pages. |
Final Office Action received for U.S. Appl. No. 13/267,383, dated Oct. 25, 2013, 8 pages. |
Final Office Action received for U.S. Appl. No. 13/534,658, dated Aug. 23, 2016, 11 pages. |
Final Office Action received for U.S. Appl. No. 13/615,107, dated Sep. 1, 2015, 9 pages. |
Final Office Action received for U.S. Appl. No. 13/646,570, dated Dec. 23, 2014, 10 pages. |
Final Office Action received for U.S. Appl. No. 14/271,342, dated Feb. 27, 2015, 7 pages. |
Gambihler et al., (1994). “Permeabilization of the Plasma Membrane of LI210 Mouse Leukemia Cells Using Lithotripter Shock Waves”, The Journal of Membrane Biology, 141:267-275. |
Grassi et al., (2012). “Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation”, Curr Hypertens Rep, 14:567-572. |
Grocela et al., (1997). “Intracorporeal Lithotripsy. Instrumentation and Development”, Urologic Clinics of North America, 24(1):13-23. |
Intention to Grant received for European Patent Application No. 13756766.5, dated Jan. 8, 2016, 5 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2009/047070, dated Dec. 23, 2010, 7 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2011/047070, dated Feb. 21, 2013, 7 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2012/023172, dated Aug. 15, 2013, 6 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/031805, dated Feb. 19, 2015, 11 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/039987, dated Nov. 20, 2014, 11 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/048277, dated Jan. 8, 2015, 9 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/055431, dated Feb. 26, 2015, 7 pages. |
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2013/059533, dated Mar. 26, 2015, 10 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2013/031805, dated May 20, 2013, 13 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2013/039987, dated Sep. 23, 2013, 15 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2013/048277, dated Oct. 2, 2013, 14 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2013/055431, dated Nov. 12, 2013, 9 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2013/059533, dated Nov. 7, 2013, 14 pages. |
International Search Report received for PCT Patent Application No. PCT/US2009/047070, dated Jan. 19, 2010, 4 pages. |
International Search Report received for PCT Patent Application No. PCT/US2012/023172, dated Sep. 28, 2012, 3 pages. |
International Written Opinion received for PCT Patent Application No. PCT/US2011 /047070, dated May 1, 2012, 5 pages. |
International Written Opinion received for PCT Patent Application No. PCT/US2012/023172, dated Sep. 28, 2012, 4 pages. |
International Written Opinion received for PCT Patent Application No. PCT/US2009/047070, dated Jan. 19, 2010, 5 pages. |
Kaplan et al., (1993). “Healing after Arterial Dilatation with Radiofrequency Thermal and Nonthermal Balloon Angioplasty Systems”, Journal of Investigative Surgery, 6:33-52. |
Knight, D. W., (2013). “Gas Discharge Tubes—Introduction”, G3YNH.info, Available Online at <http://g3ynh.info/disch_tube/intro.html>, pp. 1-9. |
Kodama et al., (2002). “Shock wave-mediated molecular delivery into cells”, Biochimica et Biophysica Acta, vol. 1542, pp. 186-194. |
Lauer et al., (1997). “Shock Wave Permeabilization as a New Gene Transfer Method”, Gene Therapy, 4:710-715. |
Manousakas et al., (2009). “A High-Voltage Discharging System for Extracorporeal Shock-Wave Therapy”, IFMBE Proceedings, 23:706-707. |
Mills et al., (2019). “Cracking the Code on Calcium; Initiate with BUY, $39 Target”, Canaccord Genuity—Capital Markets, U.S. Equity Research, pp. 1-63. |
Mitomo, Satoru, (2018). “Intravascular lithotripsy: A Novel Technology for Treating Calcified Coronary Stenoses”, Cardiovascular News, Online Available at <https://cardiovascularnews.com/intravascular-lithotripsy-anovel-technology-for-treating-calcified-coronary-stenoses>, pp. 1-4. |
Motisan, (2011). “Relaxation Oscillator Using a Hydrogen Thyratron”, PocketMagic, Available Online at <https://www.pocketmagic.net/relaxation-oscillator-using-a-hydrogenthyratron)>, pp. 1-5. |
Nisonson et al., (1986). “Ambulatory Extracorporeal Shockwave Lithotripsy”, Urology, 28(5):381-384. |
Non-Final Office Action received for U.S. Appl. No. 12/482,995, dated Aug. 13, 2014, 10 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/482,995, dated Feb. 11, 2011, 27 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/482,995, dated Jul. 12, 2013, 11 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/501,619, dated Jan. 28, 2014, 10 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/501,619, dated Nov. 3, 2011, 10 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/581,295, dated Dec. 21, 2012, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/581,295, dated Jan. 15, 2015, 14 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/581,295, dated Jun. 8, 2012, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 12/581,295, dated Mar. 10, 2014, 11 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/049,199, dated Dec. 12, 2011, 10 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/049,199, dated Feb. 4, 2014, 8 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/267,383, dated Apr. 19, 2013, 6 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/267,383, dated Feb. 25, 2015, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/465,264, dated Dec. 23, 2014, 13 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/465,264, dated Oct. 29, 2014, 13 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/534,658, dated Mar. 11, 2016, 12 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/615,107, dated Apr. 24, 2015, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/646,570, dated Oct. 29, 2014, 10 pages. |
Non-Final Office Action received for U.S. Appl. No. 13/646,583, dated Oct. 31, 2014, 8 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/061,554, dated Mar. 12, 2014, 14 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/079,463, dated Mar. 4, 2014, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/218,858, dated Mar. 30, 2016, 13 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/271,276, dated Aug. 4, 2014, 7 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/271,342, dated Sep. 2, 2014, 6 pages. |
Non-Final Office Action received for U.S. Appl. No. 14/515,130, dated Jan. 14, 2016, 16 pages. |
Non-Final Office Action received for U.S. Appl. No. 15/065,607, dated Feb. 22, 2018, 8 pages. |
Non-Final Office Action received for U.S. Appl. No. 15/347,486, dated Nov. 2, 2018, 8 pages. |
Notice of Acceptance Received for Australian Patent Application No. 2009257368, dated Aug. 28, 2014, 2 pages. |
Notice of Acceptance received for Australian Patent Application No. 2013315444, dated Jul. 26, 2017, 3 pages. |
Notice of Allowance received for Canadian Patent Application No. 2,727,429, dated May 26, 2015, 1 page. |
Notice of Allowance received for Chinese Patent Application No. 201380047277.3, dated Nov. 6, 2017, 2 pages (See Communication under 37 CFR § 1.98(a) (3)). |
Notice of Allowance received for Japanese Patent Application No. 2015-532052, dated Jun. 25, 2018, 3 pages (See Communication under 37 CFR § 1.98(a) K3)). |
Notice of Allowance received for U.S. Appl. No. 12/482,995, dated Dec. 24, 2014, 6 pages. |
Notice of Allowance received for U.S. Appl. No. 12/581,295, dated Jul. 10, 2015, 15 pages. |
Notice of Allowance received for U.S. Appl. No. 12/581,295, dated Jul. 29, 2015, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 13/049,199, dated Dec. 15, 2014, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 13/049,199, dated Jan. 13, 2015, 4 pages. |
Notice of Allowance received for U.S. Appl. No. 13/465,264, dated May 8, 2015, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 13/615,107, dated Dec. 31, 2015, 10pages. |
Notice of Allowance received for U.S. Appl. No. 13/646,570, dated Mar. 11, 2015, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 13/777,807, dated May 19, 2015, 13 pages. |
Notice of Allowance received for U.S. Appl. No. 13/831,543, dated Oct. 8, 2014, 14 pages. |
Notice of Allowance received for U.S. Appl. No. 14/061,554, dated Apr. 25, 2014, 8 pages. |
Notice of Allowance received for U.S. Appl. No. 14/079,463, dated Apr. 1, 2014, 5 pages. |
Notice of Allowance received for U.S. Appl. No. 14/218,858, dated Aug. 26, 2016, 8 pages. |
Notice of Allowance received for U.S. Appl. No. 14/271,276, dated Feb. 25, 2015, 8 pages. |
Notice of Allowance received for U.S. Appl. No. 14/271,342, dated Mar. 13, 2015, 5 pages. |
Notice of Allowance received for U.S. Appl. No. 14/515,130, dated May 2, 2016, 8 pages. |
Notice of Allowance received for U.S. Appl. No. 14/515,130, dated May 25, 2016, 3 pages. |
Notice of Allowance received for U.S. Appl. No. 15/065,607, dated Aug. 10, 2018, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 15/347,486, dated Aug. 29, 2019, 7 pages. |
Notice of Allowance received for U.S. Appl. No. 15/347,486, dated May 23, 2019, 8 pages. |
Office Action received for Australian Patent Application No. 2009257368, dated Apr. 28, 2014, 4 pages. |
Office Action received for Australian Patent Application No. 2009257368, dated Jul. 31, 2013, 4 pages. |
Office Action received for Australian Patent Application No. 2013315444, dated Nov. 30, 2016, 3 pages. |
Office Action received for Canadian Patent Application No. 2,727,429, dated Apr. 14, 2015, 4 pages. |
Office Action received for Chinese Patent Application No. 201380033808.3, dated Jul. 5, 2016, 9 pages. |
Office Action received for Chinese Patent Application No. 201380041656.1, dated Jul. 5, 2016, 9 pages. |
Office Action received for Chinese Patent Application No. 201380042887.4, dated Aug. 8, 2016, 9 pages. |
Office Action received for Chinese Patent Application No. 201380047277.3, dated Aug. 19, 2016, 12 pages. |
Office Action received for Chinese Patent Application No. 201380047277.3, dated Mar. 1, 2017, 10 pages. |
Office Action received for Chinese Patent Application No. 201380047277.3, dated May 16, 2017, 13 pages. |
Office Action received for Japanese Patent Application No. 2011-513694, dated Aug. 27, 2013, 6 pages. |
Office Action received for Japanese Patent Application No. 2011-513694, dated Jun. 10, 2014, 4 pages. |
Office Action received for Japanese Patent Application No. 2014-158517, dated May 19, 2015, 5 pages. |
Office Action received for Japanese Patent Application No. 2015-532052, dated Aug. 21, 2017, 12 pages. |
Office Action received for Japanese Patent Application No. 2015-532052, dated Feb. 6, 2018, 9 pages (6 pages of English Translation and 3 pages. |
Patent Owner Preliminary Response for U.S. Pat. No. 8,728,091, by the Patent Trial and Appeal Board dated Apr. 14, 2019, pp. 1-68. |
Patterson et al., (1985). “The Etiology and Treatment of delayed Bleeding following Percutaneous Lithotripsy”, The Journal of Urology, 133: 447-451. |
Petition for Inter Partes Review of U.S. Pat. No. 8,728,091, issued on May 20, 2014, 74 pages. |
Prosecution History of U.S. Appl. No. 14/079,463, issued as U.S. Pat. No. 8,728,091, 860 pages. |
Ricks, Delthia, (2019). “Long Island Doctors Using Sound Waves to Loosen Calcium Deposits from Arteries, Restore Blood Flow”, News/Health, Available Online at <https://www.newsday.com/news/health/calcium-treatment-st-francis-hospital- 1.27314331 >, pp. 1-4. |
Rosenschein et al., (1992). “Shock-Wave Thrombus Ablation, a New Method for Noninvasive Mechanical Thrombolysis”, The American Journal of Cardiology, vol. 70, pp. 1358-1361. |
Shockwavemedical.com, (2019). “Intravascular Lithotripsy (IVL)”, Available Online at <https://shockwavemedical.com/technology/intravascular-lithotripsy- ivl/?country=Egypt>, pp. 1-4. |
Tanaka et al., (2001). “A New Radiofrequency Thermal Balloon Catheter for Pulmonary Vein Isolation”, Journal of the American College of Cardiology, 38(7):2079-2086. |
Texas Instruments, (2018). “Power Management Guide”, Available Online at <http://www.ti.com/lit/sg/slvt145r/slvt145r.pdf>, pp. 1-93. |
Third Party Preissuance Submission for U.S. Appl. No. 16/694,712, filed Apr. 10, 2020, 3 pages. |
Third-Party Submission Under 37 CFR 1.290 Concise Description of Relevance for U.S. Appl. No. 16/694,712, filed Apr. 10, 2020, 5 pages. |
U.S. 2003/0176873, Chernenko et al., “Chernenko Drawings”, Fig. 4b and Fig. 5 from Drawings as filed on Mar. 12, 2002, pp. 1-2. |
Wells Fargo Securities LLC, (2019). “SWAY: Initiating With a Market Perform Rating”, Shockwave Medical Inc., pp. 1-34. |
Zhong et al., (1997) “Transient Oscillation of Cavitation Bubbles Near Stone Surface During Electrohydraulic Lithotripsy”, Journal of Endourology, 11(1):55-61. |
Zhong et al., (1997). “Publication Information—Transient Oscillation of Cavitation Bubbles Near Stone Surface During Electrohydraulic Lithotripsy”, Journal of Endourology, 11(1):55-61, 1 page. |
Achim et al., “Applications of shock waves in medicine”, Handbook of Shock Waves. Academic Press, 2001, pp. 1-80. |
Akiyama et al., “Current-voltage characteristics of a high-current pulsed discharge in air”, IEEE, Apr. 1988, 1 page. |
Annotated Diagram from 8,728,091 Patent, May 20, 2014, 1 page. |
Armstrong Ehrin, “Responses to Question 6 by Patent Owner's Declarants Ehrin Armstrong”, Jan. 29, 2020, 5 pages. |
Armstrong Ehrin, “Responses to Questions 1-5 by Patent Owner's Declarants Ehrin Armstrong”, Jan. 24, 2020., 4 pages. |
Barkhordarian, Vrej, “Power Mosfet basics”, Powerconversion and Intelligent Motion-English Edition, 1996, pp. 1-13. |
Breakthrough Devices Program Guidance for Industry and Food and Drug Administration Staff, U.S. Food & Drug Administration, Dec. 18, 2018. |
Brinton, et al., “Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses”, Circulation, vol. 139, Feb. 5, 2019, pp. 1-2. |
By et al., “Compliant vs Non-Compliant Balloons”, Japanese Heart Journal, vol. 39, No. 1, 1998, 1 page. |
Cavanaugh, Kenneth. “Shockwave Intravascular Lithotripsy System with the Shockwave C2 Coronary IVL Catheter”, U.S. Food & Drug Administration, Center for Devices and Radiological Health., Aug. 19, 2019, 2 pages. |
Challenging Calcium Made Shockingly Easy, Shockwave IVL, 2019, 4 pages. |
Claim Chart showing correspondence between the claims of U.S. Pat. No. 8,728,091 and the Shockwave C2 Device, 2020, 6 pages. |
Claim Chart showing correspondence between the claims of U.S. Pat. No. 8,728,091 and the Shockwave M5 Device, 2020, 6 pages. |
Claim Chart showing correspondence between the claims of U.S. Pat. No. 8,728,091 and the Shockwave S4 Device, 2020, 6 pages. |
Clara, Santa, “Shockwave Medical Reports Second Quarter 2019 Financial Results”, Globe Newswire, Aug. 5, 2019, 3 pages. |
CoolMOS 1) Power MOSFET Advanced Technical Information IXKR 47N60C5, IXYS, 2008, pp. 1-5. |
Coronary Intravascular Lithotripsy (IVL) System Instructions for Use (IFU), Shockwave C2., May 2018, pp. 1-48. |
Coronary IVL System Step-by-Step Setup, Shockwave C2, 2018, pp. 1-11. |
Coronary Tech Sheet, Shockwave C2, 2018, pp. 1-2. |
Decision for U.S. Pat. No. 8,728,091, by the Patent Trial and Appeal Board dated Jul. 11, 2020, IPR2019-00409, Jul. 11, 2020, pp. 1-72. |
Declaration and Curriculum Vitae of Dr. Daniel W. Van Der Weide, Case IPR2019-00409, 2020, 148 pages. |
Declaration of Dean Kereiakes, Case IPR2019-00409, Oct. 31, 2019, 12 pages. |
Declaration of Ehrin J. Armstrong, Nov. 2, 2019, 69 pages. |
Declaration of Jonathan M. Hill, Case IPR2019-00409, Mar. 11, 2019, 32 pages. |
Declaration of Natalie J. Grace, Case IPR2019-00409, Nov. 3, 2019, 9 pages. |
Declaration of Peter Soukas, Case IPR2019-00409, Nov. 2016, 66 pages. |
Declaration of Sean Lyden, Case IPR2019-00409, Oct. 31, 2019, 12 pages. |
Declaration of William Patrick Stephens, Case IPR2019-00409, Nov. 2, 2019, 4 pages. |
Deposition Exhibit from Deposition of Dr. Jensen, Handwritten Diagram, Feb. 24, 2020, 1 page. |
Deposition of Peter Soukas, Case TPR2019-00405, Nov. 2016, pp. 1-66. |
Deposition Transcript (compressed) of Daniel van der Weide, Case No. IPR2019-00409, Jan. 10, 2020, 111 pages. |
Deposition Transcript (compressed) of Dr. Morten Olgaard Jensen in Case No. IPR2019-00409, Oct. 14, 2019., pp. 1-90. |
Deposition Transcript (compressed) of Dr. Morten Olgaard Jensen, Case No. IPR2019-00409, Feb. 24, 2020, pp. 1-82. |
Deposition Transcript (compressed) of Ronald David Berger, Case No. IPR2019-00405, Jan. 27, 2020., 103 pages. |
Diagram, Deposition Exhibit from Deposition of Dr. Jensen, Feb. 24, 2020, 1 page. |
Dill, et al., “A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study)”, European Heart Journal, vol. 21, No. 21, Oct. 2000, pp. 1-2. |
Dr. Jensen, “Dr. Jensen's drawings of his opinion of a typical symbol for a gas discharge tube”, Oct. 14, 2019, 1 page. |
Dr. Jensen, “Eleg 2104—Electric Circuits I Course Syllabus”, Feb. 24, 2020, pp. 1-2. |
Dual Full Bridge PWM Motor Driver, Instruments, Texas., Jul. 2011, pp. 1-29. |
Email correspondence between parties and Patent Trial and Appeal Board, IPR2019-00408; IPR2019-00409, Jan. 20, 2020, 3 pages. |
Evidence of Ph.D. for Dr. Achim M. Loske, ORCID Connecting Research and Researchers, 2019, pp. 1-6. |
Filed Under Seal—Parties & Board Only—Deposition Transcript (compressed) of Dr. Morten Olgaard Jensen, Case No. IPR2019-00408, Feb. 26, 2020., pp. 1-80. |
Final Written Decision for U.S. Pat. No. 8,728,091, by the Patent Trial and Appeal Board dated Jul. 8, 2020, Jul. 8, 2020, pp. 1-72. |
Gottlieb, Scott, “U.S. Department of Health and Human Services, Food and Drug Administration Report to Congress by Scott Gottlieb”, Exhibit 1217, Sep. 30, 2018, 10 pages. |
Havanur Sanjay, “Power MOSFET Basics—Understanding Voltage Ratings”, Application Note AN851, Jan. 12, 2017, 4 pages. |
Hill, Jonathan., “Deposition Transcript (compressed) of Jonathan M. Hill, M.D.”, Exhibit 1211, Case No. IPR2019-00408, U.S. Pat. No. 9,642,673, Dec. 16, 2019., 63 pages. |
How (not) to destroy a relay, Deposition Exhibit from Deposition of Dr. Jensen, Feb. 24, 2020, pp. 1-7. |
IXYS High Voltage Power MOSFET data sheet for IXTF1N450, IXYS Corporation, 2013, 7 pages. |
Kereiakes, Deanj., “Deposition Transcript (compressed) of Dean J. Kereiakes”, Exhibit 1213, Cases No. 2019-00405, 00408 and 00409, Jan. 7, 2020., 65 pages. |
Locher Ralphe. “On switching inductive loads with power transistors”, IEEE Transactions on Industrial Electronics and Control Instrumentation 4, 1970, pp. 256-262. |
Martov et al., “Comparative In Vitro Study of the Effectiveness of Nanosecond Electrical Pulse and Laser Lithotripters”, Journal of Endourology, vol. 27, No. 10, Oct. 2013, 1 page. |
Modern Dictionary of Electronics, Sixth Edition, 1984, 5 pages. |
Narui et al., “A Spice model for simulating arc discharge loads”, IEEE, Sep. 28-Oct. 4, 1991, 1 page. |
Neuwave Microwave Ablation System, Johnson & Johnson Medical Devices Companies, Available at: (https://www.jnjmedicaldevices.com/en-us/product/neuwavemicrowave-ablation-system, 2019, 4 pages. |
Notice of Allowance received for U.S. Appl. No. 16/554,497, dated Nov. 14, 2019, 13 pages. |
Operator'S Manual, “Intravascular Lithotripsy (IVL) Generator and Connector Cable”, LBL 61876 Rev. E, Mar. 2018, pp. 1-16. |
Patent Owner's Response, Case No. IPR2019-00409, Nov. 3, 2019, 65 pages. |
Patent Owner's Sur-Reply for U.S. Pat. No. 8,728,091, by the Patent Trial and Appeal Board dated Mar. 13, 2020, Case IPR2019-00409, Mar. 13, 2020, 30 pages. |
Patents, ShockwaveMedical.com, 2019, 2 pages. |
Peripheral Intravascular Lithotripsy (IVL) Catheter Instructions for Use (IFU), LBL 61932, Rev A Instructions for Use US, Jan. 2018, pp. 1-5. |
Peripheral Intravascular Lithotripsy (IVL) Catheter Instructions for Use (IFU), LBL 61959, Rev. B Instructions for Use, Jun. 2018, pp. 1-7. |
Petitioner'S Reply Brief, Case IPR2019-00409, Feb. 14, 2020, 31 pages. |
Pitchbook Profile Previews: Shockwave Medical, Available at: https://pitchbook.com/profiles/company/58446-10, 2019, pp. 1-3. |
Publicly available Professional & Educational Background Summary for (Michelle) Li., Exhibit 1225, 2018, 1 page. |
Publicly available Professional & Educational Background Summary for Clifton Alferness, Exhibit 1229, 2013, 3 pages. |
Publicly available Professional & Educational Background Summary for Dale Skelton, Exhibit 1228, 2013, 3 pages. |
Publicly available Professional & Educational Background Summary for Daniel Hawkins, Exhibit 1226, 2018, 2 pages. |
Publicly available Professional & Educational Background Summary for Doug Hakala, Exhibit 1222, 2016, 5 pages. |
Publicly available Professional & Educational Background Summary for John Adams, Exhibit 1221, 2009, 2 pages. |
Publicly available Professional & Educational Background Summary for Mauricio Jochinsen, 2010, 4 pages. |
Publicly available Professional & Educational Background Summary for Randy Holmberg, Exhibit 1223, 2014, 3 pages. |
Publicly available Professional & Educational Background Summary for Tammo Heeren, Exhibit 1224, 2018, pp. 1-2. |
Publicly available Professional & Educational Background Summary for Valery Diamant, Exhibit 1257, 2017, 2 pages. |
Shockwave Announces Pricing of Initial Public Offering, News Release Details, Mar. 6, 2019, 2 pages. |
Shockwave Medical Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Financial Outlook, News Release Details, Feb. 13, 2020, 5 pages. |
ShockWave Medical, Inc. (SWAV), Yahoo! Finance, Nov. 1, 2019, pp. 1-3. |
Soukas Peter, “Deposition Transcript of Peter Soukas,” Cases: IPR2019-00405, IPR2019-00408, IPR2019-00409, Dec. 30, 2019, 81 pages. |
Soukas, et al., “IVL for calcium: when does it work?”, Presentation Slides for TCT 2019, TCTMD, 2019, pp. 1-87. |
Speights Keith, “5 Top Medical Device Stocks to Buy Now”, Aug. 3, 2019, pp. 1-15. |
ST data sheet and specifications for STW9N150 Power MESH Power Mosfet, www.st.com, Jan. 2008, 12 pages. |
Stephens William, “Deposition Transcript (compressed) of William Patrick Stephens”, Case No. IPR2019-00408, Jan. 22, 2020, 55 pages. |
Stone, Gregg, “Chapter 2: Use of IVL to Maintain Transfemoral TAVR Access”, Partial Video Transcript of Shockwave TCTMD Roundtable, Accessible at <https://rutherfordmedicine.com/videos/Chapter-2-Use-Of-Ivl-To-Maintain-Transfe-F53891BD1>, 2020, 1 page. |
Stone, Gregg, “Chapter 4: Current Trends, Best Practices & Updates with Peripheral IVL”, Partial Video Transcript of Shockwave TCTMD Roundtable, Accessible at <https://rutherfordmedicine.com/videos/Chapter-4-Current-Trends-Best-Practices-95444B7E1>, 2020, 2 pages. |
Stone, Gregg, “Chapter 6: IVL Roundtable Summary & Key Takeaways”, Partial Video Transcript of Shockwave TCTMD Roundtable, 2020, 1 page. |
Stone, Gregg, “Chapter 5: Insights from EU Coronary Use & Overview of Disrupt CAD III St”, Partial Video Transcript of Shockwave TCTMD Roundtable, Accessible at <https://rutherfordmedicine.com/videos/Chapter-5-Insights-From-Eu-Coronary-Use-F6027EAA2>, 2020, 1 page. |
Supplemental Declaration of Dr. Morten Olgaard Jensen, Case IPR2019-00409, U.S. Pat. No. 8,728,091 B2, Feb. 14, 2020, 54 pages. |
Switching Inductive Loads, Deposition Exhibit from Deposition of Dr. Jensen, Feb. 24, 2020, 1 page. |
The American Heritage Dictionary of the English Language, New College Edition, 1978, 4 pages. |
Third edition: Medical Design Standards for Power Supplies, International Standard, 2005, pp. 1-288. |
Transforming Breast Conserving Surgery Through Precise Surgical Navigation a Localization-Free Alternative, Elucent Medical, 2018, 1 page. |
Tsuruta, et al., “A Model of Gas Temperature Decay After Arc Extinction of Small Air Gaps”, Proceedings of the 3rd International Conference on Properties and Applications of Dielectric Materials, Jul. 8-12, 1991, pp. 1-4. |
Umemoto, et al., “TCT-362 A novel fully percutaneous thrombectomy technique with balloon occlusion guiding catheter and over-the-wire Fogarty catheter for acute limb ischemia”, Journal of the American College of Cardiology, vol. 70, No. 18, 2017, 1 page. |
United States Securities and Exchange Commission, Form 10-Q for ShockWave Medical, Inc., Aug. 6, 2019, pp. 1-39. |
Webster's New Collegiate Dictionary, G. & C. Merriam Co, 1977., 4 pages. |
Weide Daniel, “Deposition Transcript (compressed) of Daniel van der Weide, Ph.D.”, Exhibit 1203, Case No. IPR2019-00408, U.S. Pat. No. 9,642,673 B2, Jan. 13, 2020, 94 pages. |
Ziad et al., “Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Stenoses”, Circulation: Cardiovascular Intervention, 2019, pp. 1-29. |
Opening Brief of Appellee Cardiovascular Systems, Inc. for Case No. 20-2251, dated Mar. 31, 2021, 72 pages. |
Opening Brief of Appellant Shockwave Medical, Inc. for Case No. 20-2251, dated Jan. 20, 2021, 159 pages. |
Number | Date | Country | |
---|---|---|---|
20200085459 A1 | Mar 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14218858 | Mar 2014 | US |
Child | 15347486 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15347486 | Nov 2016 | US |
Child | 16694712 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13615107 | Sep 2012 | US |
Child | 14218858 | US |